GGrantIndex
← Leaderboards

Virginia D Winn

University Of Colorado Denver

$8,197,345
Attributed
$15,541,241
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY201023
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$15,541,241 · 5

By mechanism

R01$15,106,376 · 4
R21$434,865 · 1

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Pregnancy

Research focus

PregnancyPre-EclampsiaBaseWomanLeadCellsPlacentaTissuesMothersInfantResponseAffectBlood CirculationPlayVascular Endothelial Growth FactorsMyocardial InfarctionInsightPathway InteractionsDiagnosticCause Of DeathBiologicalCardiovascular SystemAccountingHypertension

Grant awards (22)

3/3- A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$308,480
R01 · FY2023 · HD
Molecular images and machine learning to extract placental function from maternal cfDNA$591,753
R01 · FY2022 · HD
3/3- A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$308,488
R01 · FY2022 · HD
Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk$2,278,257
R01 · FY2021 · HL
Molecular images and machine learning to extract placental function from maternal cfDNA$591,753
R01 · FY2021 · HD
3/3- A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$308,501
R01 · FY2021 · HD
Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk$2,192,149
R01 · FY2020 · HL
Molecular images and machine learning to extract placental function from maternal cfDNA$603,830
R01 · FY2020 · HD
3/3- A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$322,852
R01 · FY2020 · HD
Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk$2,217,157
R01 · FY2019 · HL
Molecular images and machine learning to extract placental function from maternal cfDNA$603,830
R01 · FY2019 · HD
3/3- A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$313,002
R01 · FY2019 · HD
Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk$2,267,445
R01 · FY2018 · HL
Molecular images and machine learning to extract placental function from maternal cfDNA$737,430
R01 · FY2018 · HD
P-Exo-CyTOF: Opportunity to Assess Human Placental Function in Real-Time$236,115
R21 · FY2016 · HD · contact PI
P-Exo-CyTOF: Opportunity to Assess Human Placental Function in Real-Time$198,750
R21 · FY2015 · HD · contact PI
Functional significance of Siglec-6, a novel leptin receptor, in human placental$181,733
R01 · FY2014 · HD · contact PI
Functional significance of Siglec-6, a novel leptin receptor, in human placental$104,401
R01 · FY2014 · HD · contact PI
Functional significance of Siglec-6, a novel leptin receptor, in human placental$285,809
R01 · FY2013 · HD · contact PI
Functional significance of Siglec-6, a novel leptin receptor, in human placental$295,826
R01 · FY2012 · HD · contact PI
Functional significance of Siglec-6, a novel leptin receptor, in human placental$294,993
R01 · FY2011 · HD · contact PI
Functional significance of Siglec-6, a novel leptin receptor, in human placental$298,687
R01 · FY2010 · HD · contact PI